153 related articles for article (PubMed ID: 9644639)
1. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
Shoji T; Nishizawa Y; Kawagishi T; Kawasaki K; Taniwaki H; Tabata T; Inoue T; Morii H
J Am Soc Nephrol; 1998 Jul; 9(7):1277-84. PubMed ID: 9644639
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
[TBL] [Abstract][Full Text] [Related]
3. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Nordestgaard BG; Lewis B
Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic lipoproteins in end-stage renal disease.
Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S30-3. PubMed ID: 11576918
[TBL] [Abstract][Full Text] [Related]
5. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
Shoji T; Hatsuda S; Tsuchikura S; Kimoto E; Kakiya R; Tahara H; Koyama H; Emoto M; Tabata T; Nishizawa Y
Atherosclerosis; 2009 Dec; 207(2):579-84. PubMed ID: 19540497
[TBL] [Abstract][Full Text] [Related]
6. IDL, VLDL, chylomicrons and atherosclerosis.
Nordestgaard BG; Tybjaerg-Hansen A
Eur J Epidemiol; 1992 May; 8 Suppl 1():92-8. PubMed ID: 1505659
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
8. Arterial stiffness in predialysis patients with uremia.
Shinohara K; Shoji T; Tsujimoto Y; Kimoto E; Tahara H; Koyama H; Emoto M; Ishimura E; Miki T; Tabata T; Nishizawa Y
Kidney Int; 2004 Mar; 65(3):936-43. PubMed ID: 14871413
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
[TBL] [Abstract][Full Text] [Related]
10. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
[TBL] [Abstract][Full Text] [Related]
12. Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients.
Schreier L; González AI; Elbert A; Berg G; Wikinski R
Metabolism; 2004 Aug; 53(8):1013-5. PubMed ID: 15281010
[TBL] [Abstract][Full Text] [Related]
13. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
[TBL] [Abstract][Full Text] [Related]
14. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
Nishizawa Y; Shoji T; Kawagishi T; Morii H
Kidney Int Suppl; 1997 Nov; 62():S90-2. PubMed ID: 9350691
[TBL] [Abstract][Full Text] [Related]
16. Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis.
Oda H; Yorioka N; Okushin S; Nishida Y; Kushihata S; Ito T; Yamakido M
Nephron; 1997; 76(1):7-14. PubMed ID: 9171293
[TBL] [Abstract][Full Text] [Related]
17. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.
Steinmetz A; Kirklies A; Schlosser G; Cassel W; Peter JH; Ehlenz K; Schäfer JR; Wichert PV; Kaffarnik H
Clin Investig; 1993 Feb; 71(2):145-9. PubMed ID: 8461626
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF
Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
Tatami R; Mabuchi H; Ueda K; Ueda R; Haba T; Kametani T; Ito S; Koizumi J; Ohta M; Miyamoto S; Nakayama A; Kanaya H; Oiwake H; Genda A; Takeda R
Circulation; 1981 Dec; 64(6):1174-84. PubMed ID: 7296792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
